A Synthesis Programme at Cambridge

Chemists will build complex molecules from scratch, designing new reactions and tools to make the process faster and more efficient. This matters because synthesising many natural and pharmaceutical compounds is currently slow, wasteful, or simply impossible with existing methods. The research tackles a fundamental gap: the lack of reliable, general-purpose reactions for constructing intricate molecular structures. Without new chemical tools, progress in drug development, materials science, and agrochemicals stalls. If successful, the project will deliver a suite of new synthetic methods and reactions. These could shorten the production routes for medicines, reduce chemical waste, and enable the creation of molecules that were previously out of reach. The impact would ripple through industries that depend on custom molecules—pharmaceuticals, fine chemicals, and advanced materials—making manufacturing cheaper, greener, and more versatile. This is primarily fundamental science. The researchers are not targeting a specific drug or product. Instead, they are expanding the core toolkit of organic chemistry. Past work of this kind has underpinned entire classes of antibiotics, cancer therapies, and polymers. Deeper understanding of how to build molecules reliably often leads to unexpected applications years later.